Trials / Completed
CompletedNCT02385032
Comparative Bioavailability Study of UDCA
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate bioavailability of two formulations of ursodiol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ursodiol | |
| DRUG | URSO Forte |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-03-01
- Completion
- 2015-05-01
- First posted
- 2015-03-11
- Last updated
- 2015-05-07
Source: ClinicalTrials.gov record NCT02385032. Inclusion in this directory is not an endorsement.